<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01738269</url>
  </required_header>
  <id_info>
    <org_study_id>CIM RD001</org_study_id>
    <nct_id>NCT01738269</nct_id>
  </id_info>
  <brief_title>Elecsys HE4 Chinese Reference Value Study</brief_title>
  <official_title>A Multi-center Reference Value Study of Elecsys HE4 in Chinese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to provide specimens for establishing reference values of HE4 in an
      apparently healthy Chinese population using the Roche Elecsys HE4 assay tested on variety of
      Elecsys and cobas brand immunoassay analyzers. This reference range will be compared to
      population of subjects who have signs and symptoms of various benign and malignant diseases,
      including ovarian cancer. This reference range will also be compared to the levels of HE4 in
      individual subjects who have been diagnosed with ovarian cancer and are being followed
      longitudinally for recurrence or progression of their disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Establish reference in Chinese population</measure>
    <time_frame>October 2012 - March 2013</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">2351</enrollment>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Apparently healthy subjects</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-malignant conditions subjects</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Malignant conditions subjects</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Except for samples from apparently healthy subjects, specimens for the entire clinical
        section are supposed to be available in banks / archives. Thus, for the most part, no
        prospective collection of serum should be necessary. Pseudonymized residual samples will be
        used. All elements of the clinical part require samples from well characterized cohorts are
        showed below.

          1. Apparently Healthy: 300

          2. Non-malignant Conditions: 650

          3. Malignant Conditions: 800
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (all cohorts):

          -  appropriate clinical data

          -  normal appearance of sample

          -  minimum 0.5 ml volume available

        Exclusion Criteria (all cohorts):

          -  &lt; 18 years of age

          -  insufficient volume

          -  insufficient clinical information

          -  &gt; 3 freeze/thaw cycles of samples

          -  Stored or shipped at &gt; 0Â°C

          -  Icteric, lipemic, hemolytic, substantial particulates
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>China PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Yat-Sen University Cancer Center</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shandong University Qilu Hospital</name>
      <address>
        <city>Jinan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fudan University Shanghai Cancer Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin Cancer Hospital</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xinjiang Medical University Cancer Center</name>
      <address>
        <city>Urumchi</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital Tongji Medical Colege of HUST</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2012</study_first_submitted>
  <study_first_submitted_qc>November 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2012</study_first_posted>
  <last_update_submitted>July 30, 2013</last_update_submitted>
  <last_update_submitted_qc>July 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Yaping Tian</investigator_full_name>
    <investigator_title>Director of Biochemistry Department</investigator_title>
  </responsible_party>
  <keyword>Ovarian cancer, HE4, normal range</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

